BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakamaki A, Kamimura K, Abe S, Tsuchiya A, Takamura M, Kawai H, Yamagiwa S, Terai S. Spontaneous regression of hepatocellular carcinoma: A mini-review. World J Gastroenterol 2017; 23(21): 3797-3804 [PMID: 28638219 DOI: 10.3748/wjg.v23.i21.3797] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Vernuccio F, Cannella R, Porrello G, Calandra A, Midiri M, Furlan A, Brancatelli G. Uncommon imaging evolutions of focal liver lesions in cirrhosis. Abdom Radiol (NY) 2019;44:3069-77. [PMID: 31222462 DOI: 10.1007/s00261-019-02101-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kawaguchi T, Nakano D, Okamura S, Shimose S, Hayakawa M, Niizeki T, Koga H, Torimura T. Spontaneous regression of hepatocellular carcinoma with reduction in angiogenesis-related cytokines after treatment with sodium-glucose cotransporter 2 inhibitor in a cirrhotic patient with diabetes mellitus. Hepatol Res 2019;49:479-86. [PMID: 30180287 DOI: 10.1111/hepr.13247] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sano S, Nakata S, Wada S, Kuroiwa M, Sakai H, Kusama K, Machida T, Nishio A, Ito I, Sodeyama H. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report. World J Surg Oncol 2019;17:229. [PMID: 31878937 DOI: 10.1186/s12957-019-1772-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Mahajan A, Shetty A, Koteshwar P, Musunuri B, Shetty S, Bhat G. Complete Regression of Hepatocellular Carcinoma with Low Dose of Sorafenib. J Clin Exp Hepatol 2021;11:756-7. [PMID: 34866855 DOI: 10.1016/j.jceh.2021.06.012] [Reference Citation Analysis]
5 Franses JW, Bhan I, Pankaj A, Ting DT, Deshpande V, Tanabe K. Spontaneous Immune-Mediated Regression of Hepatocellular Carcinoma With High Tumor Mutational Burden. JCO Precis Oncol 2021;5:PO. [PMID: 34585041 DOI: 10.1200/PO.21.00092] [Reference Citation Analysis]
6 Kakuta N, Yasumoto T, Yoshida Y, Tsuda M, Miyazaki A, Miyamoto S, Inada R, Yorifuji H, Higami Y, Tetsumoto S, Miyazaki M, Katada Y, Naito M. Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma. Radiol Case Rep 2021;16:1530-4. [PMID: 33948129 DOI: 10.1016/j.radcr.2021.03.027] [Reference Citation Analysis]
7 Abdraboh ME, Essa ZS, Abdelrazzak AB, El-Far YM, Elsherbini Y, El-Zayat MM, Ali DA. Radio-sensitizing effect of a cocktail of phytochemicals on HepG2 cell proliferation, motility and survival. Biomed Pharmacother 2020;131:110620. [PMID: 32892028 DOI: 10.1016/j.biopha.2020.110620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Chino F, Pollis KE, Choi S, Salama JK, Palta M. Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report. Hepatology 2018;68:1653-5. [PMID: 29888796 DOI: 10.1002/hep.30100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
9 Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H. Complete response by vitamin K2 analog monotherapy in sorafenib-failure advanced hepatocellular carcinoma: A case report. Hepatol Res 2019;49:360-4. [PMID: 30051950 DOI: 10.1111/hepr.13237] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Akahoshi S, Yamamura K, Sato N, Oda E, Kinoshita K, Yuki H, Motohara T, Deguchi A, Komohara Y, Beppu T. A hepatic sclerosed hemangioma with drastic changes in contrast-enhanced ultrasonography. Clin J Gastroenterol 2020;13:1252-7. [PMID: 32705537 DOI: 10.1007/s12328-020-01194-5] [Reference Citation Analysis]
11 Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, Berthelsen MF, Riedel M, Cai H, Joseph JV, Perouzel E, Tiraby M, Vendelbo MH, Paludan SR. The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene 2020;39:1652-64. [PMID: 31740782 DOI: 10.1038/s41388-019-1108-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
12 Katano K, Yoshimitsu Y, Kyuno T, Haba Y, Maeda T, Kitamura S. Temporary spontaneous regression of male breast cancer: a case report. Surg Case Rep 2020;6:311. [PMID: 33284403 DOI: 10.1186/s40792-020-01088-1] [Reference Citation Analysis]
13 Jacobs MN, Colacci A, Corvi R, Vaccari M, Aguila MC, Corvaro M, Delrue N, Desaulniers D, Ertych N, Jacobs A, Luijten M, Madia F, Nishikawa A, Ogawa K, Ohmori K, Paparella M, Sharma AK, Vasseur P. Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens. Arch Toxicol 2020;94:2899-923. [PMID: 32594184 DOI: 10.1007/s00204-020-02784-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
14 Venniyoor A. Synergism between anti-angiogenic and immune checkpoint inhibitor drugs: A hypothesis. Med Hypotheses 2021;146:110399. [PMID: 33239232 DOI: 10.1016/j.mehy.2020.110399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]